Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Indian J Pathol Microbiol ; 2022 Sept; 65(3): 705-708
Article | IMSEAR | ID: sea-223330

ABSTRACT

Anaplastic large cell lymphoma (ALCL) is a subcategory of the mature T-cell neoplasm characterized by sheets of cluster of differentiation (CD)30-positive pleomorphic large cells mostly present as lymphadenopathy. Here, we describe a case of Small cell variant ALCL with leukemic presentation without lymphadenopathy. A 68-year-old male presented with fatigue and weakness; examination revealed a total leukocyte count of 295,000/uL. The peripheral smear showed cells having cerebriform nuclei comprising 90% of the leukocytes. The flow cytometry showed that the cells were immunopositive for CD3 (weak), CD4, CD7, and negative for the rest of the markers. The cell blocks from the peripheral blood showed cells with immunopositivity for CD30, anaplastic lymphoma kinase (ALK), and Epithelial membrane antigen (EMA). A diagnosis of the small cell variant of ALK-positive ALCL was made. Due to the presence of atypical pleomorphic cells without lymphadenopathy, the case has a diagnostic dilemma with differential diagnosis of Sezary syndrome, T-cell prolymphocytic leukemia, and adult T-cell leukemia/lymphoma. Karyotyping and additional immunohistochemistry help for the confirmation of the diagnosis.

2.
Indian J Cancer ; 2015 Oct-Dec; 52(4): 599-603
Article in English | IMSEAR | ID: sea-176297

ABSTRACT

CONTEXT AND AIM: The prognosis of primary gliosarcoma (PGS) remains dismal with current treatment modalities. We analyzed the outcome of PGS patients treated with concurrent and adjuvant temozolomide (TMZ). SETTINGS AND DESIGN: Retrospective single institutional analysis. MATERIALS AND METHODS: We retrospectively evaluated 27 patients of PGS treated with radiotherapy (RT) and TMZ during 2007‑2012. STATISTICAL ANALYSIS USED: Overall survival (OS) was estimated by the use of Kaplan Meier method and toxicities were evaluate using common terminology criteria for adverse events version 2.0 (National Cancer Institute, USA). RESULTS: Median age at presentation and Karnofsky performance status was 45 years and 90 respectively and male: female ratio was 20:7. Patients received adjuvant RT to a total dose of 60 Gy at 2 Gy/fraction. All patients except 5 received adjuvant TMZ to a median number of 6 cycles. Grade 2 and 3 hematological toxicity was seen in 8% and 4% of patients respectively during concurrent RT. During adjuvant chemotherapy, 13.6% had Grade 3 thrombocytopenia and 9.5% had Grade 3 neutropenia. Median OS was 16.7 months (1 year and 2 year actuarial OS was 70.8% and 32.6% respectively). Adjuvant TMZ was associated with a better survival (median survival 21.21 vs. 11.93 months; P = 0.0046) on univariate analysis and also on multivariate analysis (hazard ratio 1.82, 95% confidence interval: 1.503‑25.58; P = 0.012). CONCLUSIONS: The results of our study, largest series of patients with PGS treated with concurrent and adjuvant TMZ shows an impressive survival with acceptable toxicity. We suggest TMZ be included in the “standard of care” for this tumor.

3.
Indian J Cancer ; 2015 Oct-Dec; 52(4): 590-597
Article in English | IMSEAR | ID: sea-176292

ABSTRACT

BACKGROUND AND OBJECTIVE: Neurocytoma (NC) is a rare benign neuronal tumor. A complete excision remains curative for most of these tumors, but atypical histology and extra‑ventricular location often necessitates adjuvant therapy. We intended to explore the clinico‑pathological features and treatment outcome in patients of NC in our institute. MATERIALS AND METHODS: Medical records were reviewed and data collected on NC over a 6‑year period (2006‑2012) from the departmental archives. Disease free survival (DFS) was analyzed by Kaplan‑Meier method. RESULTS: A total of 18 patients met the study criteria. Fourteen patients had intra‑ventricular neurocytoma (IVNC), right lateral ventricle being the most common site of origin. Gross total resection and near total resection were achieved in eight cases each whereas tumor decompression and biopsy could be done in two cases. On post‑operative histopathological examination, eight patients were found to have atypical NC while 10 patients had typical NC. All patients underwent adjuvant radiation. The median dose of post‑operative radiation was 56 Gy. All patients were alive at their final follow‑up. One patient had both clinical and radiological evidence of local relapse. In the evaluable patients (n = 18), after a median follow‑up of 35 months the DFS rate at 2 years and 3 years are 100% and 83% respectively. CONCLUSION: Use of adjuvant radiation to a total dose of 56 Gy enhances the local control and achieves superior survival in patients of NC. Use of 3D conformal planning techniques may help us to achieve better therapeutic ratio in patients with NC.

4.
Indian J Cancer ; 2014 Oct-Dec; 51(4): 598-599
Article in English | IMSEAR | ID: sea-172666
5.
Indian J Cancer ; 2014 Jul-Sep; 51(3): 241-244
Article in English | IMSEAR | ID: sea-154365

ABSTRACT

Background: Malignant tumors of the trachea are rare. A multimodality treatment approach is often necessary. Outcomes of radical non-surgical approaches are sparse. Radiation combined with sequential or concurrent chemotherapy is an important treatment option. Materials and Methods: We present an analysis of outcomes using modern radiotherapy and chemotherapy for tracheal tumors. Results: Radiation dose escalation using modern techniques is of benefit for these tumors. The results with chemotherapy are encouraging. Conclusions: Radiation plays a distinct role and should be a part of treatment for these tumors. The role of chemotherapy needs to be studied further.


Subject(s)
Chemoradiotherapy/methods , Chemoradiotherapy/trends , Humans , Chemoradiotherapy/statistics & numerical data , Tracheal Neoplasms/drug therapy , Tracheal Neoplasms/radiotherapy
6.
Article in English | IMSEAR | ID: sea-168142

ABSTRACT

Background: Worldwide primary angioplasty is a recommended strategy of reperfusion in patient with acute myocardial infarction as because it ensures reperfusion of the infarct-related vessels more than 90% where as, with thrombolytics it is only 60-70%. Methods: It is a retrospective observational study includes all patients treated with primary angioplasty at United Hospital from Between March 2007 to August 2010. Total 237 consecutive patients with acute myocardial infarction were treated with primary angioplasty were included. Those presented beyond 12 hours of onset of chest pain, in cardiogenic shock, resuscitate and intubated before the procedural were excluded from the study. Results: Majority (76%) of the patient were male, age was minimum 28 years and maximum 80 years, 41.5% were diabetics, 58.4% were hypertensive, 43.5 %were dyslipidaemic, 17% were smoker, 29.3% with positive family history. Fifty seven percent patients presented with anterior MI, 42 % with inferior MI and 1 % with lateral MI. Left anterior descending (LAD) is the most common vessel involved (S7%), followed by Right coronary artery (RCA) 31 %, Left circumflex artery (LCD 8 %, Ramus 1.3 % and Graft vessel 2.7%. Our door to balloon time was minimum 23 min, maximum 184 min. We used drug eluting stents for most of the patients , GP IIbIIIa receptor Mockers used in 50% cases and thrombus suction device were used when indicated. We faced complications like arrhythmias in 24% hypotension in18 %, no flow or slow flow in 45%, cardiac arrest in 3% and coronary perforation in 1. %. Our overall survival was 97.9 %. Conclusion: Primary angioplasty is a emerging area in the context 149-154of our country . Many of the new centers start this novel strategy which helps to save many lives. Primary angioplasty is feasible and safe method of reperfusion in patient with acute myocardial infarction in our center.

7.
Article in English | IMSEAR | ID: sea-168094

ABSTRACT

Background: Carotid angioplasty & stenting is becoming an emerging therapeutic option for carotid revascularization. The use of cerebral protection system has expanded the area of application of the procedure worldwide. Purpose: To assess the feasibility, success rate, safety as well as in-hospital & early 30 days outcome in patients undergoing percutaneous carotid intervention. Methods: A retrospective, observational study where a total of 18 (Eighteen) consecutive patients who presented with symptomatic and > 70 % carotid artery stenosis & asymptomatic but > 90% stenosis underwent percutaneous carotid intervention. All of them had coronary artery disease; CABG was done in 3 patients & PCI in 9 patients. Three of them had previous stroke (Ischemic) & 7 had TIA. Results: Technical and angiographic success was achieved in all patients. Carotid artery obstruction diminishes from 85 + 14 % to 10 + 5 % (p< .001). Mean lesion length was 12 + 3 mm and mean time of carotid occlusion during balloon inflation was 10 + 2.5 sec. distal protection devices used in all patents. No major stroke or death occurred during procedure. One patient developed No-flow because of obstruction of distal protection device which was managed by thrombosuction. One patient developed TIA. All patients were discharged from hospital after an average of 3 days & all of them were prescribed dual antiplatalet therapy for 6 months. During follow-up one patient died secondary to acute myocardial infarction and one patient developed major stroke. Conclusion: Percutaneous angioplasty and stenting associated with distal protective devices appear feasible, effective and almost safe endovascular treatment modality for carotid artery stenosis.

8.
West Indian med. j ; 54(2): 135-138, Mar. 2005.
Article in English | LILACS | ID: lil-410035

ABSTRACT

OBJECTIVE: Although transrectal ultrasound-guided prostatic biopsies are associated with significant discomfort and pain, most urologists do not use any kind of anaesthesia. We therefore compared the efficacy of two local anaesthetics, namely, the rectal administration of lidocaine gel and lidocaine periprostatic infiltration prior to biopsies. DESIGN AND METHODS: Three hundred and fifty-six randomized patients received either 15 mL of 2 lidocaine gel administered intrarectally ten minutes before prostate biopsies in group 1 (180 patients) or 10 mL of 1 lidocaine given under ultrasound guidance in two periprostatic injections of 5 mL, four minutes before the biopsies in group 2 (176 patients). A visual analogue scale (VAS) was used to assess the pain score during anaesthesia (VAS 1), during the biopsies (VAS 2) and 30 minutes after them (VAS 3). RESULTS: Patients receiving lidocaine gel experienced statistically less pain than the lidocaine injection group for mean VAS 1 (0.1 vs 1.4, p < 0.0001) and mean VAS 3 (0.8 vs 1.4, p < 0. 001) but VAS 2 showed no statistically significant difference (2.0 vs 2.1). No major morbidity was noted with either anaesthetic. CONCLUSION: Rectal administration of lidocaine gel is both safe, simple and effective and results are more satisfactory than with lidocaine periprostatic infiltration


Objetivo: Aunque las biopsias prostáticas transrectales guiadas mediante ultrasonido se asocian con considerable malestar y dolor, la mayoría de los urólogos no usa cualquier tipo de anestesia. Por lo tanto, comparamos la eficacia de dos anestésicos locales, a saber, la administración rectal de gel de lidocaína y la infiltración con lidocaína del área periprostática antes de las biopsias. Diseño y métodos: Trescientos cincuenta y seis pacientes randomizados recibieron o bien 15 mL de lidocaína en gel al 2%, administrada intrarectalmente diez minutos antes de las biopsias de la próstata en el grupo 1 (180 pacientes); o alternativamente 10 mL de lidocaína al 1% administrada bajo la guía de ultrasonido en dos inyecciones periprostáticas de 5 mL, cuatro minutos antes de las biopsias en el grupo 2 (176 pacientes). Se usó una escala analógica visual (EAV) para evaluar el grado de dolor durante la anestesia (EAV 1), durante las biopsias (EAV 2) y 30 minutos después de realizarlas (EAV 3). Resultados: Los pacientes que recibieron lidocaína en gel, experimentaron menos dolor estadísticamente, que el grupo de la inyección de lidocaína, para la VAS 1 media (0.1 frente a 1.4, p <0.0001) y VAS 3 media (0.8 frente a 1.4, p <0.001). Sin embargo, la VAS 2 no mostró diferencia significativa alguna en términos estadísticos (2.0 frente a 2.1). No se vio morbosidad de consideración con ninguno de los anestésicos. Conclusión: La administración rectal de gel de lidocaína es tan segura y simple como efectiva, y siendo los resultados más satisfactorio que aquellos producidos con la infiltración periprostática de lidocaína..


Subject(s)
Humans , Male , Aged , Anesthesia, Local/methods , Anesthetics, Local/administration & dosage , Biopsy , Lidocaine/administration & dosage , Prostate/pathology , Decision Making , Administration, Rectal , Prostatic Diseases/diagnosis , Pain/diagnosis , Pain/epidemiology , Endosonography , Guadeloupe/epidemiology , Incidence , Injections , Pain Measurement , Prostate , Rectum , Patient Satisfaction
9.
Indian J Public Health ; 2000 Apr-Jun; 44(2): 58-64
Article in English | IMSEAR | ID: sea-109640

ABSTRACT

A cross-sectional study was conducted among the pregnant women in three administrative divisions of West Bengal to undertake a rapid assessment about the magnitude of the problem of anaemia in pregnancy and also to study care seeking behaviour for the same. The findings revealed that the occurrence of anaemia in these three divisions were very high to the extent of 86.39% and popularly known as 'Raktasunyata" or 'Raktalpata' to the common people. As per WHO guidelines (< 40% prevalence) it could be considered as public health problem of very high magnitude. Caregivers prescribed iron supplementation only in 70% of registered pregnant women when 100% coverage of pregnant women with IFA tablet is our national goal. Amongst this group 72.2% were partially consuming these tablets. Main reason for irregular or partial consumption was inability to purchase iron tablets (52.63%). Around 16% mothers were taking rest for 2 hours at daytime during pregnancy. Most important reasons for not consuming iron tablets were that iron was prescribed on the day of study (43.18%) and iron was not prescribed even though mothers were registered (36.23%). Focus group discussion highlighted some factors regarding improvement of the situation.


Subject(s)
Anemia/diagnosis , Cross-Sectional Studies , Female , Focus Groups , Humans , India/epidemiology , Iron/therapeutic use , Mothers/psychology , Patient Acceptance of Health Care , Pregnancy , Pregnancy Complications, Hematologic/diagnosis , Prevalence
10.
Indian J Exp Biol ; 1996 Feb; 34(2): 107-10
Article in English | IMSEAR | ID: sea-59116

ABSTRACT

Cell surface hydrophobicity measurement of S. marcescens and its two mutants, one having capacity of overproducing the red pigment prodigiosin, while another carrying no pigment, showed that the hydrophobicity, which always increased with ageing of the cells, was not totally due to the pigment present on the surface. The mutant having no pigment always exhibited higher hydrophobicity than that of two pigmented cells, irrespective of whether the experimented cells were of early log phase or static phase. The outer membrane proteins were isolated and characterized by SDS-polyacrylamide gel. The non-pigmented cell outer membrane showed an extra band of protein (approximately 40 K Da molecular weight) besides the other bands common to those of other two pigmented cells. This extra protein of outer membrane may be responsible for higher surface hydrophobicity of non-pigmented mutant of S. marcescens.


Subject(s)
Bacterial Outer Membrane Proteins/isolation & purification , Cell Membrane/physiology , Serratia marcescens/physiology , Solubility , Water/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL